RCUS Shares Outstanding History



Below is a table of the RCUS shares outstanding history going back to 3/15/2018:

Date RCUS Shares Outstanding
3/15/201841.65M
5/1/201844.45M
8/1/201844.46M
11/1/201844.45M
3/1/201944.53M
4/29/201944.54M
7/30/201945.85M
10/30/201945.86M
2/28/202045.97M
4/30/202046.05M
7/31/202064.91M
10/31/202064.92M
4/30/202171.00M
7/30/202171.39M
10/29/202170.25M
2/12/202271.06M
4/29/202271.72M
7/29/202272.16M
10/28/202272.41M
2/17/202373.01M
5/3/202373.11M
8/2/202374.50M
11/1/202374.86M
2/14/202490.86M
5/1/202490.95M
8/1/202491.43M

Also see: RCUS Market Cap History
RCUS YTD Return
RCUS Historical Shares Outstanding:
+13.10% CAGR
RCUS Historical Shares Outstanding: +13.10% CAGR

Mouse over chart for data details
3/15/2018 ...8/1/2024
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer therapies. Co.'s products include: Domvanalimab, which is an anti-TIGIT monoclonal antibody designed to promote sustained immune activation and tumor clearance; Etrumadenant, which is a dual A2a/A2b adenosine receptor antagonist, designed to inhibit the adenosine-driven impairment of tumor-infiltrating lymphocytes and myeloid cells; AB680, which is a potent and selective small-molecule CD73 inhibitor designed to provide differential benefits relative to monoclonal antibodies; and Zimberelimab, which is Co.'s anti-PD-1 antibody that Co. in-licensed to enable the development of its combination regimens. We show 26 historical shares outstanding datapoints in our coverage of RCUS's shares outstanding history.

Understanding the changing numbers of RCUS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RCUS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RCUS by allowing them to research RCUS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree RCUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arcus Biosciences (RCUS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

RDHL Shares Outstanding History
RDNT Shares Outstanding History
RDY Shares Outstanding History
REGN Shares Outstanding History
RENB Shares Outstanding History
REPH Shares Outstanding History
REPL Shares Outstanding History
REPR Shares Outstanding History
RETA Shares Outstanding History
REXN Shares Outstanding History
More Healthcare companies »

 

RCUS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.